Clinical Phenotypes and the Clinical Course of Bullous Pemphigoid Receiving Dipeptidyl Pepitidase-4 Inhibitor Treatment: An Analysis of Cases in a Single Japanese Center

OBJECTIVE: Several studies have shown an increased risk of bullous pemphigoid (BP) when receiving dipeptidyl pepitidase-4 inhibitor (DPP-4i) treatment. The present study explored the associations of DPP-4i treatment with the clinical phenotypes and clinical course of BP. METHODS: We analyzed data of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Yosuke, Toyoda, Masao, Saito, Nobumichi, Kaneyama, Noriko, Shimizu, Tomomichi, Mabuchi, Tomotaka, Fukagawa, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332970/
https://www.ncbi.nlm.nih.gov/pubmed/36328578
http://dx.doi.org/10.2169/internalmedicine.0815-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332970/
https://www.ncbi.nlm.nih.gov/pubmed/36328578
http://dx.doi.org/10.2169/internalmedicine.0815-22

Ejemplares similares